Digital calculator provides the estimated risk for GIST recurrence

(Netmedi) Finnish digital technology company Netmedi has developed an online calculator that significantly improves the process of evaluating the risk of GIST (Gastrointestinal Stromal Tumor) recurrence and the need for additional treatment after surgery. The calculator is based on a risk analysis model published in 2012 by HUCH Cancer Center and Aalto University and is intended to be used in cancer care and research.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news